Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
admin 23rd May 2018 Uncategorised 0Johnson & Johnson executives predict Zytiga won’t face generic competition this year, but that doesn’t mean it won’t face a new knockoff. Sun Pharma’s branded version, a tweak on Zytiga’s active ingredient, just won FDA approval.
More: Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
Source: fierce